# Penile Length Restoration in Men With Diabetes Mellitus, Type II

Study · id `cardio:ct-nct03756688` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03756688](<https://clinicaltrials.gov/study/NCT03756688>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03756688

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 110 participants.

## Technical summary

Registry record NCT03756688. Randomized; triple masking; primary purpose treatment. Start 2018-11-07 (actual); primary completion 2021-03-18 (actual). Results posted on 2023-02-21.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 110 participants (enrolled count; ClinicalTrials.gov record NCT03756688, source copy `cardio:ctgov-nct03756688-2023-02-21`, retrieved 2026-10-26)
- Started: 2018-11-07 (actual) (ClinicalTrials.gov record NCT03756688, source copy `cardio:ctgov-nct03756688-2023-02-21`, retrieved 2026-10-26)
- Primary completion: 2021-03-18 (actual) (ClinicalTrials.gov record NCT03756688, source copy `cardio:ctgov-nct03756688-2023-02-21`, retrieved 2026-10-26)
- Completion: 2021-03-18 (actual) (ClinicalTrials.gov record NCT03756688, source copy `cardio:ctgov-nct03756688-2023-02-21`, retrieved 2026-10-26)
- Results first posted: 2023-02-21 (ClinicalTrials.gov record NCT03756688, source copy `cardio:ctgov-nct03756688-2023-02-21`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT03756688, source copy `cardio:ctgov-nct03756688-2023-02-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03756688-2023-02-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: Penile Length Restoration in Men With Diabetes Mellitus, Type II
- Condition: Diabetes Mellitus, Type 2
- Condition: Penile Diseases
- Intervention (Device): RestoreX PTT - 6 months
- Intervention (Device): RestoreX PTT - 3 months
- Lead sponsor: Mayo Clinic
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Mayo Clinic (`cardio:org-mayo-clinic`)

## Provenance

Content hash: 209e54f93eca9fb0e11009ec7cc02d8fe8d0d3cc763cf250b33534868b01baa5
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
